Literature DB >> 14412879

The response of chronically hospitalized, lobotomized patients to treatment with chlorpromazine and reserpine.

A A KURLAND, T G WILLIAMS, T E HANLON.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapy; PSYCHOSES/therapy; PSYCHOTHERAPY; RESERPINE/therapy

Mesh:

Substances:

Year:  1959        PMID: 14412879     DOI: 10.1007/bf01562037

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


× No keyword cloud information.
  13 in total

1.  Effects of chlorpromazine in psychiatric disorders; report of clinical observations and impressions in 1000 cases.

Authors:  I M COHEN
Journal:  Am J Med Sci       Date:  1955-04       Impact factor: 2.378

2.  Drugs affecting psychotic behavior and the function of the mesodiencephalic activating system.

Authors:  F RINALDI; H E HIMWICH
Journal:  Dis Nerv Syst       Date:  1955-05

3.  Neuropharmacological aspects of reserpine.

Authors:  J A SCHNEIDER; A J PLUMMER; A E EARL; R GAUNT
Journal:  Ann N Y Acad Sci       Date:  1955-04-15       Impact factor: 5.691

4.  Significance of selected central mechanisms for the analysis of the action of reserpine.

Authors:  H J BEIN
Journal:  Ann N Y Acad Sci       Date:  1955-04-15       Impact factor: 5.691

5.  Comparison of chlorpromazine and reserpine in treatment of schizophrenia; a study of four hundred cases.

Authors:  A A KURLAND
Journal:  AMA Arch Neurol Psychiatry       Date:  1956-05

6.  Preliminary report on 500 patients treated with thorazine at Rochester State Hospital.

Authors:  B POLLACK
Journal:  Psychiatr Q       Date:  1955-07

7.  The challenge of bio- and chemotherapy in psychiatry.

Authors:  F MARTI-IBANEZ; A M SACKLER; M D SACKLER; R R SACKLER
Journal:  J Clin Exp Psychopathol       Date:  1956 Jan-Mar

8.  Chlorpromazine in the treatment of schizophrenia; a study of 75 cases.

Authors:  A A KURLAND
Journal:  J Nerv Ment Dis       Date:  1955-04       Impact factor: 2.254

9.  Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states.

Authors:  H E LEHMANN; G E HANRAHAN
Journal:  AMA Arch Neurol Psychiatry       Date:  1954-02

10.  Therapeutic results with chlorpromazine (largactil) in psychiatric conditions.

Authors:  H E LEHMANN
Journal:  Can Med Assoc J       Date:  1955-01-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.